Adicet Bio (ACET) vs Serina Therapeutics (SER)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Adicet Bio (ACET) has outperformed Serina Therapeutics (SER) over the past year, losing 54.7% versus a loss of 62.8%. Over five years, SER leads with a -93.9% price change compared with -95.2% for ACET. Adicet Bio is the larger company by market cap ($54.1 million vs $50.8 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACET | SER |
|---|---|---|
| Share price | $5.78 | $2.00 |
| Market cap | $54.06M | $50.80M |
| 1-day change | -6.55% | -0.50% |
| YTD return | -26.60% | +5.07% |
| 1-year return | -54.72% | -62.78% |
| 5-year return | -95.20% | -93.88% |
| EPS (TTM) | $-10.42 | $-1.87 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $17.44 | $5.71 |
| 52-week low | $5.55 | $1.22 |
| Distance from 52-week high | -66.89% | -64.98% |
| Average volume | 166.29K | 64.02K |
| Shares outstanding | 9.36M | 25.40M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ACET vs SER FAQ
Which is bigger, Adicet Bio or Serina Therapeutics?
Adicet Bio (ACET) is larger, with a market capitalization of $54.06M compared with $50.80M for Serina Therapeutics (SER).
Which stock has performed better over the past year, ACET or SER?
ACET returned -54.72% over the past 12 months, compared with -62.78% for SER (price return, excluding dividends). Past performance does not predict future results.
Are Adicet Bio and Serina Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.